# Christiane Ahlers

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christiane-ahlers/

## Facts

| Field | Value |
| --- | --- |
| Citations | 471 |
| Field | Hormonal Regulation and Hypertension |
| h-index | 10 |
| i10-index | 10 |
| Last Known Institution | FIND |
| OpenAlex ID | https://openalex.org/A5113897568 |
| Works | 32 |

## Researcher papers

- [Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program](https://scholariq.org/papers/safety-and-tolerability-of-dienogest-in-endometriosis-pooled-analysis-from-the/)
- [A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes](https://scholariq.org/papers/a-prespecified-exploratory-analysis-from-fidelity-examined-finerenone-use-and/)
- [Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes](https://scholariq.org/papers/outcomes-with-finerenone-in-participants-with-stage-4-ckd-and-type-2-diabetes/)
- [Integrated results from the COPERNICUS and GALILEO studies](https://scholariq.org/papers/integrated-results-from-the-copernicus-and-galileo-studies/)
- [Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice](https://scholariq.org/papers/effectiveness-of-dienogest-in-improving-quality-of-life-in-asian-women-with/)
- [Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies](https://scholariq.org/papers/predictors-of-visual-outcomes-in-patients-with-neovascular-age-related-macular/)
- [Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease](https://scholariq.org/papers/association-of-finerenone-use-with-reduction-in-treatment-emergent-pneumonia-and/)
- [The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the <scp>FIDELITY</scp> study](https://scholariq.org/papers/the-impact-of-obesity-on-cardiovascular-and-kidney-outcomes-in-patients-with/)
- [Bleeding patterns with the 19.5 mg LNG-IUS, with special focus on the first year of use: implications for counselling](https://scholariq.org/papers/bleeding-patterns-with-the-19-5-mg-lng-ius-with-special-focus-on-the-first-year/)
- [Pooled analysis of bleeding profile, efficacy and safety of oral oestradiol valerate/dienogest in women aged 25 and under](https://scholariq.org/papers/pooled-analysis-of-bleeding-profile-efficacy-and-safety-of-oral-oestradiol/)
- [Finerenone in People with CKD, Type 2 Diabetes, and History of Nephrectomy](https://scholariq.org/papers/finerenone-in-people-with-ckd-type-2-diabetes-and-history-of-nephrectomy/)

## Researcher topics

- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [FIND](https://scholariq.org/institutions/find/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.